Intestinal Mucosal Immune Barrier: A Powerful Firewall Against Severe Acute Pancreatitis-Associated Acute Lung Injury via the Gut-Lung Axis
Fan Li,Zhengjian Wang,Yinan Cao,Boliang Pei,Xinyu Luo,Jin Liu,Peng Ge,Yalan Luo,Shurong Ma,Hailong Chen
DOI: https://doi.org/10.2147/jir.s448819
IF: 4.5
2024-04-10
Journal of Inflammation Research
Abstract:Fan Li, 1– 3, &ast Zhengjian Wang, 4, &ast Yinan Cao, 1– 3 Boliang Pei, 1– 3 Xinyu Luo, 1– 3 Jin Liu, 1– 3 Peng Ge, 1– 3 Yalan Luo, 1– 3 Shurong Ma, 1, 3 Hailong Chen 1– 3 1 Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China; 2 Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China; 3 Laboratory of Integrative Medicine, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China; 4 Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shurong Ma; Hailong Chen, Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Zhongshan Road 222, Dalian, Liaoning, 116011, People's Republic of China, Tel +86-411-83635963, Fax +86-411-83622844, Email ; The pathogenesis of severe acute pancreatitis-associated acute lung injury (SAP-ALI), which is the leading cause of mortality among hospitalized patients in the intensive care unit, remains incompletely elucidated. The intestinal mucosal immune barrier is a crucial component of the intestinal epithelial barrier, and its aberrant activation contributes to the induction of sustained pro-inflammatory immune responses, paradoxical intercellular communication, and bacterial translocation. In this review, we firstly provide a comprehensive overview of the composition of the intestinal mucosal immune barrier and its pivotal roles in the pathogenesis of SAP-ALI. Secondly, the mechanisms of its crosstalk with gut microbiota, which is called gut-lung axis, and its effect on SAP-ALI were summarized. Finally, a number of drugs that could enhance the intestinal mucosal immune barrier and exhibit potential anti-SAP-ALI activities were presented, including probiotics, glutamine, enteral nutrition, and traditional Chinese medicine (TCM). The aim is to offer a theoretical framework based on the perspective of the intestinal mucosal immune barrier to protect against SAP-ALI. Keywords: severe acute pancreatitis-associated acute lung injury, intestinal mucosal immune barrier, gut microbiota, gut-lung axis, migration of immune cells Severe acute pancreatitis (SAP) is one of the most common abdominal critical emergencies in clinical practice. According to the 2012 Revision of the Atlanta Classification Standard (RAC) by the International AP Consensus and the 2014 Guidelines for diagnosis and treatment of the acute pancreatitis guide by the Chinese medical association branch, SAP is defined as acute inflammation of pancreas, and its main manifestations include pancreatic edema, necrosis, hemorrhage, infection, peripancreatic fluid collection, wall necrosis (WON), and extrapancreatic organ dysfunction or failure. 1,2 The main cause is the destruction of pancreatic acinar cells and bile duct cells, leading to the activation of trypsin and lipase in pancreatic tissue. 3,4 And it is often accompanied by organ failure lasting for more than 48 hours. The pathological process is characterized by an aggressive nature and the potential involvement of one or multiple organs, resulting in a mortality rate of up to 35% 5,6. The incidence of SAP has increased in recent years, with an estimated number of 110 to 140 cases per 100,000 population. 4,7–9 Acute lung jury is one of the most serious and earliest complications secondary to SAP, which usually manifests as a decrease in alveolar surface-active substances, an elevation in oxygen-free radicals and permeability of alveolar epithelial cells, accumulation of inflammatory proteins, and injury to the endothelial cells of the pulmonary microvasculature. This accounts for 70% of the mortality rate among patients with SAP. 10–12 The occurrence of SAP-ALI is typically accompanied by the release of inflammatory mediators in a cascading manner, disruption of the intestinal barrier function, imbalance of immune systems, as well as alterations in intestinal bacteria and their pathogen-associated molecular patterns (PAMPs). 13–16 SAP-ALI as a typical complication of SAP, is the main cause of death in SAP patients, and its mortality rate is more than 30%. 17–23 The current focus of SAP-ALI research is to find ways to reduce the inflammatory response and the expression of inflammatory factors. 24,25 Endotoxemia, systemic inflammatory response syndrome and multiple-organ fa -Abstract Truncated-
immunology